pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
ICT-568
Thyroid Cancer
Innovative Cellular Therapeutics Co Ltd
Preclinical
ICT-6401
Autoimmune Disorders
Innovative Cellular Therapeutics Co Ltd
Preclinical
ID-119040338
Parkinson's Disease
Yunovia Co Ltd
Phase 1
← prev
page 94 of 231
next →
131
Pain
89
Neurology
1
IDE-034
Castration-Resistant Prostate Cancer (CRPC)
$IDYA
IDEAYA Biosciences, Inc.
Phase 2
IDE-161
Colon Cancer
$IDYA
IDEAYA Biosciences, Inc.
Phase 2
IDE-275
Endometrial Cancer
$IDYA
IDEAYA Biosciences, Inc.
Phase 2
IDE-397
Adenoid Cystic Carcinoma (ACC)
$IDYA
IDEAYA Biosciences, Inc.
Phase 1
IDE-574
Breast Cancer
$IDYA
IDEAYA Biosciences, Inc.
Phase 1
IDE-892
Esophageal Squamous Cell Carcinoma (ESCC)
$IDYA
IDEAYA Biosciences, Inc.
IDKIT HP ONE
IDKIT HP ONE (CITRIC ACID ANHYDROUS AND 13C UREA)
no indication
MERIDIAN BIOSCIENCE
Phase 1
IDOV-Immune
Solid Tumor
Viromissile Inc
Phase 3
IFxHu-20
Merkel Cell Carcinoma
TuHURA Biosciences Inc
Phase 2
IGV-001
Glioblastoma Multiforme (GBM)
Imvax Inc
Phase 2
IIV-HD + rC19
Coronavirus Disease 2019 (COVID-19)
$SNY
Sanofi
Preclinical
IK-01400
Inflammatory Pain
InterK Peptide Therapeutics Ltd
Phase 1
IKS-03
B-Cell Non-Hodgkin Lymphoma
Iksuda Therapeutics Ltd
Preclinical
IKS-04
Bile Duct Cancer (Cholangiocarcinoma)
Iksuda Therapeutics Ltd
Preclinical
IL-2106
Gastric Cancer
iLEAD Biomedical Science Inc
Preclinical
IL-21120033
Idiopathic Pulmonary Fibrosis
iLEAD Biomedical Science Inc
Phase 2
IM-101
Myasthenia Gravis
ImmunAbs Inc
Phase 1
IM-1021
Diffuse Large B-Cell Lymphoma
$IMNM
Immunome Inc.
Preclinical
IM-1240
Adenocarcinoma Of The Gastroesophageal Junction
$PPBT
PURPLE BIOTECH LTD.
Phase 1
IM-3050
Solid Tumor
$IMNM
Immunome Inc.
Phase 2
IMA-203CD8
Solid Tumor
Immatics NV
IMATINIB
IMATINIB
no indication
DR REDDYS
Phase 2
IMB-101
Hidradenitis Suppurativa
Navigator Medicines Inc
Phase 1
IMC-002
Solid Tumor
ImmuneOncia Therapeutics Inc
Preclinical
IMC-008
Gastric Cancer
Suzhou Immunofoco Biotechnology Co Ltd
Phase 2
IMG-007
Atopic Dermatitis (Atopic Eczema)
$IMA
ImageneBio, Inc.
IMKELDI
IMKELDI (IMATINIB ORAL)
no indication
Shorla Oncology
